Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Breyer

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 7, 2017
Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D<sub>2</sub> Receptor Subtype 1Deping Kong, Juanjuan Li, Yujun Shen, et al.
The Journal of Experimental Medicine|September 14, 2016
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammationDeping Kong, Yujun Shen, Guizhu Liu, et al.
The Journal of Investigative Dermatology|September 16, 2006
Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressivenessSabine Brouxhon, Raymond L Konger, JoAnne VanBuskirk, et al.
Cell Metabolism|December 2, 2008
Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosisVladimir R Babaev, Joshua D Chew, Lei Ding, et al.
The American Journal of Pathology|April 25, 2009
Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2C Dirk Keene, Rubens Chang, Christina Stephen, et al.
European Journal of Immunology|March 3, 2007
Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2Ruxana T Sadikot, Heng Zeng, Anser C Azim, et al.
Anticancer Research|August 5, 2006
Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesisRobert L Keith, Mark W Geraci, S Patrick Nana-Sinkam, et al.
The Journal of Clinical Investigation|March 6, 2003
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptorLi Yang, Noboru Yamagata, Rajwardhan Yadav, et al.
American Journal of Physiology. Renal Physiology|July 18, 2008
Increased dietary NaCl induces renal medullary PGE2 production and natriuresis via the EP2 receptorJian Chen, Min Zhao, Wenjuan He, et al.
Circulation Research|April 19, 2013
Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptorJian Zhang, Fangfang Zou, Juan Tang, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|January 7, 2017
Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D<sub>2</sub> Receptor Subtype 1Deping Kong, Juanjuan Li, Yujun Shen, et al.
The Journal of Experimental Medicine|September 14, 2016
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammationDeping Kong, Yujun Shen, Guizhu Liu, et al.
The Journal of Investigative Dermatology|September 16, 2006
Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressivenessSabine Brouxhon, Raymond L Konger, JoAnne VanBuskirk, et al.
Cell Metabolism|December 2, 2008
Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosisVladimir R Babaev, Joshua D Chew, Lei Ding, et al.
The American Journal of Pathology|April 25, 2009
Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2C Dirk Keene, Rubens Chang, Christina Stephen, et al.
European Journal of Immunology|March 3, 2007
Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2Ruxana T Sadikot, Heng Zeng, Anser C Azim, et al.
Anticancer Research|August 5, 2006
Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesisRobert L Keith, Mark W Geraci, S Patrick Nana-Sinkam, et al.
The Journal of Clinical Investigation|March 6, 2003
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptorLi Yang, Noboru Yamagata, Rajwardhan Yadav, et al.
American Journal of Physiology. Renal Physiology|July 18, 2008
Increased dietary NaCl induces renal medullary PGE2 production and natriuresis via the EP2 receptorJian Chen, Min Zhao, Wenjuan He, et al.
Circulation Research|April 19, 2013
Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptorJian Zhang, Fangfang Zou, Juan Tang, et al.
Pageof 9